Your report is on its way.
Check your inbox in the next few minutes for the 2026 Commercial Drug Launch Analysis.
The report shows where launches go wrong. See the patient signals that can tell you sooner.
mama health turns direct patient conversations into patient journeys, barriers, and behavioral signals.
Patient intelligence used by teams across life sciences
Five root causes behind launch underperformance
The report identifies five recurring causes of launch underperformance. Weak patient journey mapping is where mama health goes deeper.
The report explains why launches miss. mama health helps you see where yours might.
Find the blind spots
See where patients delay, drop off, reconsider treatment, or switch — and what is driving it.
Pressure-test your assumptions
Compare the access, pathway, messaging, and treatment assumptions in your launch plan against real patient experience.
Spot signals earlier
Surface emerging barriers and behavioral changes before they show up in lagging market data.
Ask a question. Get a deep-dive back.
Ask a question about your disease area and get a structured deep-dive built from patient conversations.
It starts with patients talking about their real lives.
Direct patient conversations are structured into longitudinal journeys that life science teams can explore in the platform.
Patients recruited directly and condition-verified.
AI-moderated conversations capture patients' experiences in their own words.
Experiences are organized into journeys, barriers, needs, decisions, and behavioral signals.
Teams explore continuously refreshed patient intelligence directly in the mama health platform.
Questions teams didn't think were answerable.
What could patient intelligence reveal about your launch?
See how mama health can surface the barriers, behaviors, and treatment signals shaping your disease area.